Anti-Inflammatory Agents, Non-SteroidalIbuprofenCyclooxygenase 2 InhibitorsDiclofenacNaproxenCyclooxygenase InhibitorsSulindacAspirinPiroxicamKetoprofenProstaglandin-Endoperoxide SynthasesCyclooxygenase 2IndomethacinAcetaminophenCyclooxygenase 1SulfonamidesThiazinesPyrazolesGastrointestinal DiseasesEtodolacFlurbiprofenSulfonesNitrobenzenesAnalgesics, Non-NarcoticLactonesTolmetinKetorolacStomach UlcerGrowth Differentiation Factor 15IsoenzymesGastrointestinal HemorrhageDinoprostoneOsteoarthritisPeptic UlcerArthritisAnti-Inflammatory AgentsProstaglandinsAnalgesicsPeptic Ulcer HemorrhageRisk FactorsDose-Response Relationship, DrugFenoprofenDrug HypersensitivityGastric MucosaDrug InteractionsSodium SalicylateClonixinPainSalicylatesProstaglandin AntagonistsAnticarcinogenic AgentsMisoprostolMembrane ProteinsStereoisomerismChemopreventionCase-Control StudiesFenamatesAnti-Ulcer AgentsPhenylbutazoneUlcerPhenylpropionatesDiflunisalTropaeolaceaeMefenamic AcidSafety-Based Drug WithdrawalsUpper Gastrointestinal TractMolecular StructureDrug PrescriptionsNonsteroidal Anti-AndrogensDrug Therapy, CombinationThiazolesDuodenal UlcerIndoprofenProton Pump InhibitorsStomach DiseasesColorectal NeoplasmsIntestinal DiseasesColonic NeoplasmsOxyphenbutazoneAdenomatous PolypsPharmacoepidemiologyModels, MolecularArthritis, RheumatoidButanonesApoptosisMagnetic Resonance SpectroscopyAromatase InhibitorsProspective StudiesTreatment OutcomeMolecular ConformationPain MeasurementKetorolac TromethamineAdministration, TopicalDouble-Blind MethodFlutamideDrug UtilizationEstrogen AntagonistsPain, PostoperativePropionatesHistamine H2 Antagonists